Layer 4 is cash-pay compounded GLP-1 through telehealth platforms the same active ingredients (semaglutide, tirzepatide) prepared by licensed compounding pharmacies and sold without going through a brand
With repeat testing, higher results thus do not necessarily mean the patient is worse
A 2025 study of more than 7,000 MS patients found that those taking GLP-1 medications, including semaglutide, showed significantly less disease progression over five years than matched controls
Things that frequently drive weight gain, and that GLP-1s alone will not fix: Untreated depression or anxiety that drives emotional eating and disrupted sleep Perimenopausal hormone shifts that change body composition and insulin sensitivity ADHD-related dysregulated eating patterns (binge eating, time-blindness around meals, impulsive food decisions) Untreated thyroid dysfunction Insulin resistance, PCOS, or sleep apnea that interact with metabolism Medication side effects from antidepressants, antipsychotics, or other prescriptions This is where being a dual-board-certified Family and Psychiatric-Mental Health Nurse Practitioner changes the conversation
Remember that the L-carn takes up volume as well
Saaranen, M
.png?width=1280&auto=webp&quality=80&format=jpg&disable=upscale)
